- JAK2 inhibitors for the treatment of Philadelphia-negative myeloproliferative neoplasms: current status and future directions
Xiaofeng Liu et al, 2024, Molecular Diversity CrossRef - Targeting Janus Kinase (JAK) for Fighting Diseases: The Research of JAK Inhibitor Drugs
Min-Yan Zhao et al, 2022, Current Medicinal Chemistry CrossRef